MedTrace Logo

Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer

NCT00379119 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2012-10-11

No results posted yet for this study

Summary

RATIONALE: Studying changes in thymus function in patients who have been undergoing androgen blockade therapy for prostate cancer may help doctors learn more about how well patients will respond to treatment, may help in planning cancer treatment, and may help the study of cancer in the future.

PURPOSE: This clinical trial is studying the effect of androgen blockade therapy on thymus function in older patients who have undergone radical prostatectomy for localized prostate cancer.

Conditions

Interventions

OTHER

diagnostic laboratory biomarker analysis

OTHER

flow cytometry

OTHER

physiologic testing

PROCEDURE

computed tomography

Sponsors & Collaborators

Principal Investigators

  • Joseph M. McCune, MD, PhD · University of California, San Francisco

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00379119 on ClinicalTrials.gov